Marc Grasso, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marc Grasso, M.D.
Marc Grasso, M.D. is recorded as CFO at Kyverna Therapeutics, Inc. (KYTX). Kyverna Therapeutics, Inc. reported in an 8-K filed June 30, 2025 that Marc Grasso, M.D. was appointed Chief Financial Officer, effective June 30, 2025.
“Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the appointment of Marc Grasso, M.D., as its Chief Financial Officer (CFO), effective today.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kyverna Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Greg Martini CFO
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Mayo Pujols CTO
- Andrew Miller Board Member
- Andrew Miller, Ph.D. Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.